- Home
- CGTX vs IVAC Comparison
CGTX vs IVAC Comparison
Compare CGTX & IVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- IVAC
- Stock Information
- Founded
- CGTX 2007
- IVAC 1990
- Country
- CGTX United States
- IVAC United States
- Employees
- CGTX N/A
- IVAC N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- IVAC Industrial Machinery/Components
- Sector
- CGTX Health Care
- IVAC Technology
- Exchange
- CGTX Nasdaq
- IVAC Nasdaq
- Market Cap
- CGTX 79.3M
- IVAC N/A
- IPO Year
- CGTX 2021
- IVAC 1995
- Fundamental
- Price
- CGTX $0.44
- IVAC $2.65
- Analyst Decision
- CGTX Buy
- IVAC Hold
- Analyst Count
- CGTX 6
- IVAC 1
- Target Price
- CGTX $8.00
- IVAC N/A
- AVG Volume (30 Days)
- CGTX 476.7K
- IVAC 141.4K
- Earning Date
- CGTX 11-13-2024
- IVAC 11-11-2024
- Dividend Yield
- CGTX N/A
- IVAC N/A
- EPS Growth
- CGTX N/A
- IVAC N/A
- EPS
- CGTX N/A
- IVAC N/A
- Revenue
- CGTX N/A
- IVAC $65,569,000.00
- Revenue This Year
- CGTX N/A
- IVAC N/A
- Revenue Next Year
- CGTX N/A
- IVAC N/A
- P/E Ratio
- CGTX N/A
- IVAC N/A
- Revenue Growth
- CGTX N/A
- IVAC 28.52
- 52 Week Low
- CGTX $0.34
- IVAC $2.46
- 52 Week High
- CGTX $2.95
- IVAC $4.57
- Technical
- Relative Strength Index (RSI)
- CGTX 41.17
- IVAC 32.76
- Support Level
- CGTX $0.43
- IVAC $2.48
- Resistance Level
- CGTX $0.48
- IVAC $3.43
- Average True Range (ATR)
- CGTX 0.04
- IVAC 0.17
- MACD
- CGTX -0.01
- IVAC -0.05
- Stochastic Oscillator
- CGTX 7.26
- IVAC 19.59
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.